
Puma Biotechnology: Alisertib Deal Alters My Strategy (NASDAQ:PBYI)
wildpixel Puma Biotechnology (NASDAQ:PBYI), recently publicized a licensing deal with Takeda (TAK) for alisertib, “a selective, small-molecule, orally administered inhibitor of aurora kinase A.” Alisertib has already had experience in the clinic in several different […]